Showing results (71-80 of 455) with videos related to
Sort By:
Pageof 46
Journal of Neuro-Oncology|November 30, 2005
Immunotoxin pharmacokinetics: a comparison of the anti-glioblastoma bi-specific fusion protein (DTAT13) to DTAT and DTIL13Edward Rustamzadeh, Daniel A Vallera, Deborah A Todhunter, et al.Polymers|May 31, 2020
3D-Printed Conductive Carbon-Infused Thermoplastic PolyurethaneNamsoo Peter KimJournal of Neuro-Oncology|November 30, 2005
Osmotic blood-brain barrier disruption chemotherapy for diffuse pontine gliomasWalter A Hall, Nancy D Doolittle, Megan Daman, et al.Journal of Law and Medicine|February 2, 2024
The Standard of Care Test Revisited: Competing Approaches to Defining Competent Profession Practice in AustraliaCameron Stewart, Peter KimSeminars in Pediatric Surgery|May 16, 2015
The evolving identity, capacity, and capability of the future surgeonSharifa Himidan, Peter KimCurrent Treatment Options in Oncology|July 30, 2020
Consolidation Therapy in Primary Central Nervous System LymphomaPeter Kim, Antonio OmuroJournal of Neuro-Oncology|June 12, 2009
Intracranial elimination of human glioblastoma brain tumors in nude rats using the bispecific ligand-directed toxin, DTEGF13 and convection enhanced deliverySeunguk Oh, John R Ohlfest, Deborah A Todhunter, et al.International Journal of Cancer|December 17, 2005
Intracranial therapy of glioblastoma with the fusion protein DTIL13 in immunodeficient miceEdward Rustamzadeh, Walter A Hall, Deborah A Todhunter, et al.Journal of Neuro-Oncology|November 2, 2006
Expression of MHC I and NK ligands on human CD133+ glioma cells: possible targets of immunotherapyAnhua Wu, Steve Wiesner, Jing Xiao, et al.Biomaterials|June 14, 2016
Affinity-controlled protein encapsulation into sub-30 nm telodendrimer nanocarriers by multivalent and synergistic interactionsXu Wang, Changying Shi, Li Zhang, et al.Pageof 46